97-18-7
97-18-7
Chemical Structure
Bithionol
- CAS No.: 97-18-7
- Formula:C12H6Cl4O2S
- Molecular Weight:356.05
IUPAC Name: 6,6'-thiobis(2,4-dichlorophenol)
InChIKey: JFIOVJDNOJYLKP-UHFFFAOYSA-N
SMILES: OC1=C(Cl)C=C(Cl)C=C1SC2=CC(Cl)=CC(Cl)=C2O
Biological Activity: Bithionol is an antibacterial, anthelmintic, and algaecide agent. Bithionol is also a potent inhibitor of soluble adenylyl cyclase through binding to the allosteric activator site (IC50: 4 μM)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bithionol | 99.32% | Bithionol is an antibacterial, anthelmintic, and algaecide agent. Bithionol is also a potent inhibitor of soluble adenylyl cyclase through binding to the allosteric activator site (IC50: 4 μM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bithionol (Standard) | 98.86% | Bithionol (Standard) is the analytical standard of Bithionol. This product is intended for research and analytical applications. Bithionol is an antibacterial, anthelmintic, and algaecide agent. Bithionol is also a potent inhibitor of soluble adenylyl cyclase through binding to the allosteric activator site (IC50: 4 μM). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
p38 MAP Kinase Inhibitor IV | 99.9% | p38 MAP Kinase Inhibitor IV is a highly specific ATP-competitive p38α MAPK inhibitor with IC50s of 0.13 and 0.55 μM for p38α and p38β MAPK, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
A 9387 | A9387 is an inhibitor of the Tn3 Resolvase, which promotes site-specific recombination reactions between two directly repeated recombination sites. Several inhibitors have been isolated that inhibit this event. A9387 inhibits the binding of resolvase to the res site. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tetrasul | Tetrasul is an acaricide. Tetrasul inhibits Tetranychus urticae and aphids on hops. Tetrasul has also been used in research of erythematous (type one) rosacea. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bithionol (sulfoxide) | 99.02% | Bithionol sulfoxide is an anti-infection agent for parasites. Bithionol sulfoxide has mutagenic activity. Bithionol sulfoxide can be used in the research of parasite infection, such as paragonimiasis, flukes andcestodes infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fenticlor | Fenticlor is a topical antibacterial agent that can be used for treating acne. Fenticlor can cause photosensitivity reactions and is a known cause of phototoxic dermatitis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,3′,4,5′-Tetrachloro biphenyl-13C12 | 3,3′,4,5′-Tetrachloro biphenyl-13C12 is 13C labeled 3,3',4,5'-Tetrachloro-1,1'-biphenyl. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2,2',3,4',5,6,6'-heptachloro-1,1'-biphenyl-13C12 | 2,2',3,4',5,6,6'-heptachloro-1,1'-biphenyl-13C12 is 13C labeled 2,2',3,4',5,6,6'-Heptachloro-1,1'-biphenyl. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2,2′,3,3′,5,5′,6-Heptachloro biphenyl-13C12 | 2,2′,3,3′,5,5′,6-Heptachloro biphenyl-13C12 is 13C labeled 2,2',3,3',5,5',6-Heptachloro-1,1'-biphenyl. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl-13C12 | 2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl-13C12 (2,2',4,4',6,6'-Hexachlorobiphenyl-13C12) is 13C labeled 2,2',4,4',6,6'-Hexachloro-1,1'-biphenyl. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Florent RL, et al. In vitro toxicity of bithionol and bithionol sulphoxide to Neoparamoeba spp., the causative agent of amoebic gill disease (AGD). Dis Aquat Organ. 2010 Sep 17;91(3):257-62. [Content Brief]
- [2]. Silke Kleinboelting, et al. Bithionol Potently Inhibits Human Soluble Adenylyl Cyclase through Binding to the Allosteric Activator Site. J Biol Chem. 2016 Apr 29;291(18):9776-84. [Content Brief]
